ADAM10 in cancer diagnosis, detection and treatment

Details for Australian Patent Application No. 2006235260 (hide)

Owner Sagres Discovery, Inc. Novartis Vaccines and Diagnostics Inc.

Inventors Xu, Xie; Rowe, Michael; Yu, Guoying; Fanidi, Abdallah; Booher, Robert; Moler, Edward; Tse, Christin; Lai, Albert

Agent FB Rice

Pub. Number AU-A-2006235260

PCT Pub. Number WO2006/110583

Priority 60/669,862 07.04.05 US

Filing date 7 April 2006

Wipo publication date 19 October 2006

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110583 Priority application(s): WO2006/110583

11 December 2008 Amendment Made

  The nature of the amendment is: Add the co-inventors name to read Marc Malandro

21 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235263-Identification of a new class of EPSP synthases

2006235258-Cancer-related genes